Immunology - Breakthrough CRISPR technique unlocks insights about cancer immunology
Can't see this email? View it online
   
  Immunology  
  The latest immunology news from News Medical  
 

High-quality TL1A and DR3 Products accelerate the development of drugs for various inflammatory diseasesHigh-quality TL1A and DR3 Products accelerate the development of drugs for various inflammatory diseases

TL1A/DR3 secretes stimulatory signals that amplify effector T cell response in various inflammatory diseases, which also stimulates mucosal immune response. To support the diverse needs across targeting TL1A therapeutic drug development, ACRO are now offering high-quality TL1A recombinant proteins, DR3 recombinant protein, DcR3 recombinant protein, and TL1A stable cell line!

Find Out More
 
   Breakthrough CRISPR technique unlocks insights about cancer immunologyBreakthrough CRISPR technique unlocks insights about cancer immunology
 
Over the past two decades, the immune system has attracted increasing attention for its role in fighting cancer. As researchers have learned more and more about the cancer-immune system interplay, several antitumor immunotherapies have become FDA-approved and are now regularly used to treat multiple cancer types.
 
   New approach detects T cells in "cold" tumors, paves way for broader immunotherapyNew approach detects T cells in "cold" tumors, paves way for broader immunotherapy
 
Most cancers are thought to evade the immune system. These cancers don't carry very many mutations, and they aren't infiltrated by cancer-fighting immune cells. Scientists call these cancers immunologically "cold."
 
 Study highlights potential therapeutic target for immune-related disorders
 
Study highlights potential therapeutic target for immune-related disordersA new study has shed light on the importance of the protein STAP-1 in activating certain immune cells. Understanding the role of STAP-1 in these cells could give researchers a better glimpse into immune-related disorders and ways to treat them.
 
 
 Man takes 217 COVID vaccines with no ill effects, shows immune boost
 
Man takes 217 COVID vaccines with no ill effects, shows immune boostA case report of a 62-year-old man receiving 217 SARS-CoV-2 vaccinations over 29 months reveals no adverse effects, increased T-cells, and spike-specific antibodies, providing unique insights into the effects of hyper-vaccination on immune responses.
 
 
 Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2
 
Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use.
 
 
 COVID booster in lactating mothers can provide antibodies for infants
 
COVID booster in lactating mothers can provide antibodies for infantsLactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine, a study from the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) and the UF College of Medicine found.
 
 
 Newly identified antibodies target a hard-to-spot region of the influenza virus
 
Newly identified antibodies target a hard-to-spot region of the influenza virusResearchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein head.
 
 
 Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccines
 
Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccinesResearchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCLH have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve.
 
 
    MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.
 

Use this GPT to search for edited and trustworthy references, articles, and equipment reviews from over 20 years of trusted medical and healthcare content.

Currently only available to ChatGPT Plus account holders.

 
Ask a Question Now
 
 
 

How would you rate today's newsletter?